Literature DB >> 30242788

Influence of Transurethral Resection of Bladder Cancer on Sexual Function, Anxiety, and Depression.

Wojciech Krajewski1, Urszula Halska2, Sławomir Poletajew3, Radosław Piszczek4, Bartosz Bieżyński5, Mateusz Matyjasek3, Andrzej Tukiendorf6, Fryderyk Menzel5, Małgorzata Mazur5, Joanna Rymaszewska7, Romuald Zdrojowy5.   

Abstract

The standard of care in non-muscle invasive bladder cancer consists of transurethral tumor resection. The aim of this study was to evaluate the influence of transurethral resection of bladder tumor (TURB) on the patients' self-reported depression, anxiety, sexual satisfaction, and erectile dysfunction. Psychological condition of 252 male patients who underwent TURB was prospectively evaluated. The Hospital Anxiety and Depression Scale (HADS), simplified International Index of Erectile Function (IIEF-5), and Sexual Satisfaction Questionnaires (SSQ) were administered to patients before and 10 days after tumor resection. We found that primary anxiety, depression, and erectile dysfunction were all worse in cancer patients than those in the general population, and all further worsened after tumor resection. The post-resection worsening was influenced by the operation and catheterization time, complications, and the tumor characteristics. Taxonomical analysis shows that the greatest risk of depression aggravation concerned patients who were younger, had a higher body mass index, and a medium-sized tumor. We conclude that transurethral resection of non-muscle invasive bladder cancer may adversely affect sexual function, anxiety, and depression. Patients should be informed about potential complications to prevent the abandonment of a follow-up. The findings of this study stress the role of personalized medicine pursued by a multidisciplinary medical team.

Entities:  

Keywords:  Anxiety; Bladder cancer; Depression; Erectile dysfunction; Sexual satisfaction; Transurethral tumor resection

Mesh:

Year:  2018        PMID: 30242788     DOI: 10.1007/5584_2018_264

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed-methods systematic review.

Authors:  Claudia Rutherford; Manish I Patel; Margaret-Ann Tait; David P Smith; Daniel S J Costa; Shomik Sengupta; Madeleine T King
Journal:  Qual Life Res       Date:  2020-09-22       Impact factor: 4.147

Review 2.  Patient-Centered Outcomes in Bladder Cancer.

Authors:  John L Gore
Journal:  Curr Urol Rep       Date:  2018-10-29       Impact factor: 3.092

Review 3.  Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews.

Authors:  Lauren J Lee; Christina S Kwon; Anna Forsythe; Carla M Mamolo; Elizabeth T Masters; Ira A Jacobs
Journal:  Clinicoecon Outcomes Res       Date:  2020-11-23

4.  Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies.

Authors:  Damiano Pizzol; Tao Xiao; Lee Smith; Guillermo F López Sánchez; Andrea Garolla; Christopher Parris; Yvonne Barnett; Petre Cristian Ilie; Pinar Soysal; Jae Il Shin; Mark A Tully; Lin Yang; Nicola Veronese; Igor Grabovac
Journal:  Br J Gen Pract       Date:  2021-04-29       Impact factor: 5.386

5.  Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China.

Authors:  Peng Guo; Yu Wang; Yun-Feng Xie; Tian-Bing Lv
Journal:  Asian J Androl       Date:  2022 Sep-Oct       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.